June 29, 2022 Pete Findlay appointed Chief Operating Officer at Bega cheese SYDNEY: Bega Cheese (ASX: BGA) announced the appointment of Pete Findlay as Chief Operating Officer having responsibility for the branded business segment. Pete joined…
June 29, 2022 Inify Laboratories appoints Dr. Claes Lind as Chief Medical Officer STOCKHOLM: Inify Laboratories announces the addition of specialized medical competence to the company’s management team and organization. “We warmly welcome Dr. Claes Lind to…
June 29, 2022 Ipsen announces U.S. FDA Priority Review for palovarotene New Drug Application in Patients With Fibrodysplasia Ossificans Progressiva Following Resubmission PARIS: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its resubmitted New…
June 28, 2022 Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing PARIS: Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing…
June 28, 2022 Voyager launches CBD Refillery LONDON, UK: Voyager, the health and wellness company supplying high-quality Cannabidiol (CBD), hemp seed oil and hemp-related products, has launched a range of refillable…
June 28, 2022 Novacyt launches monkeypox assay in response to the outbreak PARIS: Novacyt, an international specialist in clinical diagnostics, announces the launch of its research-use-only (RUO) polymerase chain reaction (PCR) monkeypox assay in response to…
June 28, 2022 U.S. Government to support expansion of Croda lipid systems capability LONDON: Croda International Plc, the company that uses smart science to create high performance ingredients and technologies that improve lives, announces that it has…
June 27, 2022 poLight ASA signs a Proof-of-Concept agreement with a top tier medical customer HORTEN: poLight ASA (OSE: PLT) announced that the company has signed an agreement to support a phased PoC (Proof of Concept) endoscopic camera system…
June 27, 2022 Genflow signs research agreement with Magnitude Biosciences Limited LONDON: Genflow (LSE: GENF) has entered into a research agreement with Magnitude Biosciences Limited (“Magnitude”), a UK-based, specialist biotechnology research organisation that supports drug…
June 27, 2022 Lynparza recommended in EU for early breast cancer LONDON: AstraZeneca and MSD’s Lynparza (olaparib) has been recommended for marketing authorisation in the European Union (EU) as monotherapy or in combination with endocrine therapy for…